Transdermal administration of (R)-3,3-diphenylpropylamine monoesters

Details for Australian Patent Application No. 2004228927 (hide)

Owner Schwarz Pharma AG

Inventors Wolff, Hans-Michael; Breitenbach, Armin; Meese, Claus; Drews, Roland

Agent Griffith Hack

Pub. Number AU-B-2004228927

PCT Pub. Number WO2004/089346

Priority 103 15 878.2 08.04.03 DE

Filing date 3 April 2004

Wipo publication date 21 October 2004

Acceptance publication date 17 May 2007

International Classifications

A61K 9/70 (2006.01) Medicinal preparations characterised by special physical form - Web, sheet or filament bases

A61K 31/403 (2006.01) - condensed with carbocyclic rings, e.g. carbazole

Event Publications

21 April 2005 PCT application entered the National Phase

  PCT publication WO2004/089346 Priority application(s): WO2004/089346

17 May 2007 Application Accepted

  Published as AU-B-2004228927

13 September 2007 Standard Patent Sealed

29 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004228929-Organic compounds

2004228923-System and method for acquiring data and aligning and tracking of an eye